Impact of PD?L1 upregulation on immune checkpoint inhibitor efficacy in triple?negative breast cancer using a 4T1 murine model. Park AY, Kim JH, Lee S, Kim HS, et al. Int J Oncol 2025;67:54.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Park AY, Kim JH, Lee S, Kim HS, et al. Impact of PD?L1 upregulation on immune checkpoint inhibitor efficacy in triple?negative breast cancer using a 4T1 murine model. Int J Oncol 2025;67:54.
PMID: 40511536